Peptides and Anti-Doping: The WADA and CCES Layer, Explained

Canadian law governs what may be supplied and for what purpose. That is the system covered in are peptides legal in Canada, and it is federal, administered under the Food and Drugs Act and enforced by Health Canada.

Anti-doping is separate and contractual. Athletes in tested sport are bound, through their sport's rules, to the World Anti-Doping Agency Prohibited List,[1] which in Canada is administered by the Canadian Centre for Ethics in Sport.[2] Those rules apply regardless of whether a substance is lawful to buy, lawful to possess, or approved as a medicine anywhere.

The practical consequence is that "it is legal to purchase" answers a question no anti-doping process ever asks.

WADA revises the Prohibited List annually, so any summary written on a fixed date is a snapshot rather than an authority. The current list at wada-ama.org governs, and it is the document to check rather than this page. With that stated:

• ·Growth-hormone secretagogues and GHRH analogues. Ipamorelin, sermorelin, tesamorelin and the CJC-1295 family fall in the peptide hormones and growth factors category, which is prohibited at all times.
• ·Repair-class peptides. TB-500 and thymosin beta-4 are named on the list. BPC-157 has no regulatory approval for human use anywhere, which brings it within the non-approved substances catch-all.
• ·Melanocortins. Melanotan-class compounds are prohibited.
• ·Metabolic and incretin compounds. Treatment of this class has evolved, and anyone in tested sport should verify the current position directly rather than relying on a summary.
• ·The non-approved substances category is the one that catches almost everything else. It covers substances with no current approval by any governmental regulatory health authority for human therapeutic use, which describes most of a research catalogue by definition.

Anti-doping operates on strict liability: an athlete is responsible for what is found in their sample, regardless of how it got there and regardless of intent. There is no defence built on not knowing, and the analytical methods used in doping control are specifically developed to detect peptides at low concentrations in urine and blood.[3]

That combination is what makes contamination and mislabelling a career-level risk rather than an inconvenience, and it is why the substitution problem this catalogue writes about for quality reasons has a second and much sharper consequence for anyone in tested sport.

Some vendors in this category court athlete customers with knowing marketing. That trade generates anti-doping violations for the athletes and regulatory attention for the seller, in roughly equal measure, and it is not a trade this catalogue wants.

The accurate position is the dull one. Research compounds are supplied for laboratory work. Athletes in tested sport are subject to strict liability under a list that is revised annually. Anyone inside that system should treat every compound lacking regulatory approval for human use as prohibited unless the current WADA list says otherwise, and should be checking the list itself rather than a supplier's summary of it.